Omicron COVID booster cuts hospitalisation in over 65s: Israeli study
The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced hospitalisations among older patients, Israeli researchers ...
The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced hospitalisations among older patients, Israeli researchers ...
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German ...
Germany's BioNTech said on Wednesday it has completed construction of its first vaccine factory made from shipping containers called 'BioNtrainer' ...
Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants of Omicron, ...
BioNTech SE, the German biotech that developed a widely used COVID-19 vaccine with Pfizer Inc , will set up research ...
Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 ...
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 ...
Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) said on Saturday that a booster dose of updated versions of their COVID-19 vaccine, modified specifically to ...
A third dose of the COVID-19 vaccine from Pfizer Inc (PFE.N) and BioNTech (22UAy.DE) produced significant protection against the Omicron variant of the ...
Germany's BioNTech (22UAy.DE) has developed a vaccine factory made from shipping containers that it plans to ship to Africa as assembly kits ...
Moderna Inc said on Wednesday it had started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed ...
Pfizer Inc and Germany's BioNTech will develop an mRNA-based vaccine for the prevention of viral infection shingles, collaborating for the ...
BioNTech and Pfizer (PFE.N) said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test ...
The European Union-wide rollout of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin December 13, ...
BioNTech says it has signed an agreement with the Rwandan government and Institut Pasteur de Dakar in Senegal on the ...
Pharmaceutical giant Pfizer and BioNTech announced today, that phase two of its three-phased vaccine trial, has shown that its COVID-19 ...
Health product regulator SAHPRA has approved a Section 21 emergency use application for the COVID-19 vaccine developed by Pfizer and ...
Pfizer Inc said on Tuesday it expects to generate about $15 billion in sales this year from the COVID-19 vaccine ...
Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to lose only a small bit of effectiveness against an engineered virus with ...
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, ...